期刊文献+

多学科协作在化疗患者卵巢功能管理中的作用

Role of Multi-disciplinary Treatment in the Ovarian Function Management on Patients with Chemotherapy
下载PDF
导出
摘要 目的探讨多学科协作在化疗患者卵巢功能管理中的作用。方法多学科协作团队综合管理恶性肿瘤化疗患者卵巢生殖内分泌功能。由专病医师、药师共同组成多学科治疗团队,根据循证医学证据制定药物卵巢去势治疗方案遴选有效避孕方法、制定用药教育计划,监测卵巢储备功能减退等不良反应并制定相应的干预措施。观察多学科团队协作对患者依从性和治疗效果的影响。结果与结论多学科协作团队可提高患者的用药依从性,保护年轻恶性肿瘤化疗患者卵巢功能,提高患者生活质量。 OBJECTIVE To explore the multi-disciplinary treatment(MDT)in the management of ovarian functions in young malignant tumor patients with chemotherapy.METHODS The model of MDT service on managing ovarian function of patients with chemotherapy was established by multi-disciplinary physicians and pharmacists of specialized disease.In light of clinical evidence,decisions of treatment team and patient medication education were made,which included the development of ovarian suppression protocol,medical eligibility criteria of effective contraceptive methods,and monitoring and corresponding disposal of adverse drug reactions such as reduced ovarian reserve.Futhermore,the influence of MDT on the medication compliance was observed.RESULTS and CONCLUSION The medication compliance of patients was improved by the MDT.The ovarian function of young patients with malignant tumor may be protected from chemotherapy,and the quality of life was improved in the patients.
作者 郑翠仙 翁秀华 孙艳 曾乌查 曾晓萍 曾凡湘 ZHENG Cui-xian;WENG Xiu-hua;SUN Yan;ZENG Wu-cha;ZENG Xiao-ping;ZENG Fan-xiang(Fujian Maternity and Child Health Hospital,Affiliated Hospital of Fujian Medical University,Fuzhou 350001,China;Fujian Key Laboratory of Women and Childrens Critical Diseases Research,Fuzhou 350001,China;The First Affiliated Hospital of Fujian Medical University,Fuzhou 350005,China)
出处 《海峡药学》 2021年第12期150-153,共4页 Strait Pharmaceutical Journal
基金 福建省卫生健康青年科研课题资助(2019-2-24)。
关键词 肿瘤 化疗 卵巢功能 多学科协作团队 管理 Tumor Chemotherapy Ovarian function Multi-disciplinary treatment Management
  • 相关文献

参考文献6

二级参考文献96

  • 1沈铿.妇科恶性肿瘤保留生育功能治疗应注意的几个问题[J].中华妇产科杂志,2006,41(4):219-221. 被引量:17
  • 2沈铿,郎景和,杨佳欣,陈亦乐,向阳,华克勤,黄惠芳,潘凌亚,吴鸣,丰有吉.腹腔镜阴式广泛性子宫颈切除术治疗早期子宫颈癌的临床分析[J].中华妇产科杂志,2006,41(4):222-225. 被引量:47
  • 3Zhang J J, Wang M. Latent class joint model of ovarian function suppression and DFS for premenopausal breast cancer patients [J]. Stat Med, 2010, 29: 2310-2324.
  • 4van der Kaaij MA, van Echten-Arends J, Simons AH, et al. Fertility preservation after chemotherapy for Hodgkin lymphoma [J]. Hematol Oncol, 2010, 28.. 168-179.
  • 5Meirow D, Biederman H, Anderson RA, et al. Toxicity of chemotherapy and radiation on female reproduction [J]. ClinObstet Gynecol, 2010, 53: 727-739.
  • 6Schover LR. Rates of posteaneer parenthood [J]. J Clin Oncol, 2009, 27: 321-322.
  • 7Gracia CR, Sammet MD, Freeman E, et al. Impact of cancer therapies on ovarian reserve [J]. Fertil Steril, 2012, 97: 134-140 e1.
  • 8Koyama H, Wada T, Nishizawa Y, et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer [J]. Cancer, 1977, 39: 1403-1409.
  • 9Tomao F, Spinelli GP, Panici PB, et al. Ovarian function, reproduction and strategies for fertility preservation after breast cancer [J]. Crit Rev Oncol Hematol, 2010, 76: 1-12.
  • 10AtayaKM, McKanna JA, Weintraub AM, et al. A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats [J]. Cancer Res, 1985, 45:3651-3656.

共引文献700

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部